Home | List of Topics | Cancer | Pigmented Lesion/Melanoma
Melanoma of the eye is cancer that occurs in various structures in the eye, such as the choroid, the iris, or the ciliary body. The choroid layer is the most likely location of melanoma in the eye.
Melanoma is a very aggressive type of cancer that can spread rapidly. It often affects the skin.
Melanoma is the most common type of eye tumor in adults. Even so, primary melanoma of the eye is rare.
The cancer may only be in the eye, or it may spread to another location in the body. There may be no early symptoms, but the tumor will eventually cause a retinal detachment and distortion of vision.
Excessive exposure to sunlight is an important risk factor. The occurrence of melanoma has greatly increased in recent decades. Fair-skinned and blue-eyed people are affected most often.
An eye examination with an ophthalmoscope reveals a single round or oval lump (tumor) within the eye.
Tests may include:
Small melanomas may be treated with lasers or by radiation therapy. Chemotherapy may be needed if the tumor has spread. Surgical removal of the eye may be necessary to prevent the spread of tumor to the brain or other organs.
For additional resources, see cancer support group.
The outcome for melanoma of the eye depends upon the size of the cancer at the time of diagnosis. Between 60% and 80% of patients will survive at least 5 years from the time of diagnosis if the cancer has not spread outside the eye (metastasized).
If there has been spread outside the eye, the chance of survival is much lower.
Spread of the tumor to other areas of the body is a complication.
Call for an appointment with your health care provider if a melanoma of the eye is suspected.
The most important way to prevent eye melanoma is to avoid excessive exposure to sunlight, especially between 10 a.m. and 2 p.m., when the sun's rays are most intense. Wear sunglasses, and be sure they have ultraviolet protection.
Review Date:5/3/2006
Reviewed By:William Matsui, MD, Assistant Professor of Oncology, Division of Hematologic Malignancies, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.
Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.